Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
At this point I think the credibility of our CEO is the major concern! At this point we don’t even know if Leo is even working to save this company! We’ve been left in the dark not knowing whether Leo is still in the fight ! So at this point Bmed might be irrelevant! We need to hear from Leo
At this juncture in the history of my investment in IPIX, I believe that everything hinges upon our equity position and alliance with BeaMed Technologies, LTD.
If there is anyone on this message board that is not familiar with their amazing StingRay laser system, check out their home page. Absolutely massive revenue potential, and they are not far away from being ready to go to market in the near future. I said it before as have other investors here: A reverse merger with BeaMed and a name change with a new CEO is highly likely. If and when that happens, investors will be scrambling to buy in.
Well, it will be impossible to see any price accumulation unless we are reinstated and retail can trade this.
OR, we are bought for a bargain, but hopefully that is even in the realm of .05-.10 price.
Expert market only open to "accredited investors"--$3k this morning for over a million shares--wish I could do that...
What is an accredited investor?
An accredited investor is a person or entity that is allowed to participate in investments not registered with the SEC. These are typically high-net-worth individuals and companies with the means and experience to trade private, riskier investments.
According to the Securities and Exchange Commission, an individual accredited investor is anyone who:
Earned income of more than $200,000 (or $300,000 together with a spouse) in each of the last two years and reasonably expects to earn the same for the current year.
Has a net worth over $1 million, either individually or together with a spouse (excluding the value of a primary residence).
Is a "knowledgeable employee" of a private fund.
Is a financial professional who has Series 7, Series 65 or Series 82 financial securities licenses.
The rule is meant to help prove investors have the sophistication and means to invest in potentially riskier investments, as well as weather any losses.
“One of his favorite sources was the Pink Sheets, a weekly printed on pink paper, which gave information about the stocks of companies so small that they were not traded on a stock exchange. Another was the National Quotation book, which came out only every six months and described stocks of companies so minuscule that they never even made it into the Pink Sheets. No company was too small, no detail too obscure, to pass through his sieve.” “I would pore through volumes of businesses, and I’d find one or two that I could put ten or fifteen thousand dollars into that were just ridiculously cheap.” Alice Schroeder’s book The Snowball: Warren Buffett and the Business of Life.
Someone sold them but according to you no one should buy them. Why did they?
Somebody bought em and somebody sold em, no?
I highly doubt that!!!!!!
More likely someone decided to take their $4-5k and go home.
Probably a smart move.
fb?
Someone is still gobbling up shares at this extraordinary price!!!!
Well .. tax loss write offs for many years to come 😤 …with $3k per year … looks like for rest of my life ..🤷🏻♂️
PJ: Ever wonder where all the locust went? I bet coward PJ that Leo…Kevetrin and the wonder drug that was shelf for a reason never show up in this life time🚀to the moon mo fo hahaha idiot!!!!
Wonderful voicemail message from a public company. The official end is near.
Ha. Ehrlich and his big plans that never materialized. The one-man-Titanic- band's website is so full of misinformation it should be removed.
"Leo told us about the BoD leaving but nothing on Jane and the last hire? Strange"
Are you serious? Leo didn't even tell us about Leo.
The Director resignations required a filing and that happened on 2/1. Jane's situation does not.
Leo didn't file the 10Q or the Lateness Notification which was due on 2/15.
If Leo resigned any of his positions he was obligated to submit a filing saying so but he has done the most irresponsible thing he could possibly do.....disappear without a peep.
Leo told us about the BoD leaving but nothing on Jane and the last hire? Strange
Wow, was the volume only 1400 shares traded today? About $6 worth? Holy cow!
Either way he's likely no longer in Wakefield. Sad deal. All the positive testing and nothing more from Leo. I wonder does anybody else know if Leo still has a space in Wakefield MA?
There is no doubt that it’s only a matter of time before this stops trading. The only hope left is either for new management with finances to push the science, or leaving a shell for an eventual RM.
Here is what happened when I called. The operator says: welcome to verizon, your call can’t be completed as dialed.
I tried the number and it said the person you are trying to reach is not excepting calls at this time and to try your call again later. I would say by that it's still active.
Keep up the good work chief. Why you digging up stuff on a dead company anyhow,,, sheesh
The phone number on the contact us page of the ipix website is no longer in service. Right below the defunct phone number is this beauty: European Subsidiary (Ireland)
Good description of what IPIX has become under Ehrlich's regime...although that is more than Ehrlich has said in months.
Buk, buk, buk. 🐓
Bag holders on their way to slaughter still suckling the CEO. How sad.
Frenchbroad is still around and reading the board. Speechless I guess....I know that I would be.
https://ih.advfn.com/stock-market/USOTC/innovation-pharmaceuticals-ce-IPIX/stock-price
Sorry, but I try not to engage with trolls who have zero interest in the stock in question (this post is obviously an exception, but it will be the last such -good luck in your future endeavors).
Your post presents an ideal opportunity to demonstrate your forensic chops. Please enlighten us on how you arrived at your suppositions of frenchbroad's gender, real name (Bean), personal financial situation, relationship with Mr Ehrlich, and that frenchbroad is now in hiding. Your research seems like it entailed a lot of gumshoe work. What is your process? What are your most used investigative techniques? Did you you enlist the help of your gang members?
I'm curious about whether others on this board feel these are fair questions. I guess a positive emoji would be one way they could state how they feel about it.
"Talking of scams and those who promote them, I wonder what's happened to our fake Franglais friend, frenchbroad (aka Mr. Bean) who has been missing in action almost as long as IPIX' phantom CEO, Leo Ehrlich?
I wonder which of these apply:
1) He's merely a vastly over-extended and soon to be broke retail investor who pimps this sorry scam because he thinks he can retrieve some of hus ginormous losses.
2) He's a paid stock pimp whose remuneration has suddenly dried up
or
3) He's an insider- possibly even an Ehrlich family member, as has been hinted at on this very message board - and now he has crept away like a thief in the night to count the money he stole from Ehrlich's hapless marks? ""
Well dang professor, why didn’t you say so before? That certainly explains the thousands and thousands and thousands of posts over the past decade or so. And all this time I thought it was “intellectual curiosity”. Well, I can certainly sleep better now knowing the real truth of the matter.
I like kicking idiots in the nuts. metaphorically.
Obviously I can only answer for myself:
Do you really think that a judgment against the Company for more cash than it has, the resignation of both independent Directors, the relegation of the Company's shares to the Expert Market making them barely tradable and the literal disappearance of the CEO makes IPIX LESS interesting? Because it doesn't. And I'd like to see how those things play out.
For me the risk of hanging around is negligible.
I believe the Ignore feature is still functional. If the truth hurts you might want to use it.
By the way, regarding "if it's game over like you say it is" I never said that it was, but there aren't too many good reasons to think that it isn't.
Gee, so surprising no one answered this question. Not holding my breath for an actual answer.
BTR is a very sophisticated investor.
“So you still have your 6 million shares of a Company that filed bankruptcy?”
"Finally bankruptcy. BUT, I never sold my 6 million shares. Some entity since then paid off the bills and the judge ruled the company free and clear. It's a clean shell with a low share structure hanging there ripe for a merge."
So you still have your 6 million shares of a Company that filed bankruptcy?
What's the name of that example Company?
I think it was settled, looking into it now. I wonder what his thought is these days…
I don’t recall, did George ever get that money?
The moment Leo came in he started to take money for himself and bleed company funds.
http://www.sec.gov/Archives/edgar/data/1355250/000135525010000029/exh_99-1.htm
I have no trust left that’s it…
34248 now worth 143.84 by Monday Tuesday we go to zero..
From an old post from an ex holder in 2017:
Do you then recall how ex-CEO George Evans ever settled his dispute with Leo regarding being properly compensated ? Although I remember the dispute, can't recall the settlement.
Sounds like at the time George Evans wasn't very pleased with Leo and it prompted him to file this email with U.S. regulators;
http://www.sec.gov/Archives/edgar/data/1355250/000135525010000029/exh_99-1.htm
https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=5&cad=rja&uact=8&ved=0ahUKEwjnmaeVxtTUAhVU1mMKHStjCyIQFgg9MAQ&url=http%3A%2F%2Fwww.xconomy.com%2Fboston%2F2010%2F11%2F10%2Fformer-pfizer-exec-leaves-ceo-post-at-cellceutix%2F&usg=AFQjCNFfs0Tpl5jUhLNAdYftvU0GBNYqoQ
Best Wishes,
-bunny-
I was here back in the day when George Evans was replaced by Leo and back then Leo spoke about the little biotech that BP was so interested in and by now it is getting tiresome to hear this over and over. I still think it will, despite management, hit the mother lode. Management has made a bad impression with too large a percentage of investors and each PR gets them further in trouble.
"Speed Trader", an online trading platform for those who still want to trade Ipix shares.
It is what it is,,,,
My first Stinky Pinky had I believe the first patent for a non contact infared thermometer. They brought on board another entrepreneur who had a hypodermic needle destruction device. The Arnold the CA Govenor/terminator proposed a bill where pharmas selling needles for at home usage had to supply a safe means for disposing needles. Rumors spread Arnie was loading up shares and maybe he was because the stock Exploded, my first Otc high risk high reward investment was going up and as it did I kept buying,,,, 3 days or so later the Ceo says its all a rumor, the stock crashed. Now I'm the proverbial bag holder. Unlike Leo they took on a Toxic lender, 2 reverse splits. Finally bankruptcy. BUT, I never sold my 6 million shares. Some entity since then paid off the bills and the judge ruled the company free and clear. It's a clean shell with a low share structure hanging there ripe for a merge. Moral of the story, never give up on a stinky pinky.
"The appeal of the judgment against IPIX is due to be filed on May 8 "
Is that what this means?
"Review Appeals Filed 03/11/2024 05/08/2024"
snayeman Maybe he got a tip and was told to get out of town cause the big boys are coming to settle the score.
Followers
|
979
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
402726
|
Created
|
05/10/08
|
Type
|
Free
|
Moderators zandant Minnesinger sunspotter snayeman loanranger frenchbroad |
Innovation Pharmaceuticals Inc. (IPIX)
$IPIX NEWS - http://ipharminc.com/press-release
SEC Filings https://www.sec.gov/cgi-bin/browse-edgar?company=Innovation+Pharmaceutical&owner=exclude&action=getcompany
From the most recent 10-K:
There are doubts about our ability to continue as a going concern.
We have generated revenue of $0 and $18,000 for the fiscal years ended June 30, 2023 and 2022, respectively and have an accumulated deficit of $125.3 million through June 30, 2023. These factors raise substantial doubt about our ability to continue as a going concern.
We need to raise substantial additional capital in the future to fund our operations and we may be unable to raise such funds when needed and on acceptable terms, which could prevent us from fully implementing our business, operating and development plans.
We currently have an approximate $1.0 million cash balance as of the date of this filing, but that is insufficient to complete the development and commercialization of any of our proposed products. We expect to incur costs of approximately $1.8 million in the upcoming fiscal year ending June 30, 2024 to operate our business in accordance with our business plans and budgets.
We have limited experience in drug and formulation development, the conduct of clinical trials, and may not be able to successfully develop any drugs.
Development of pharmaceutical products is a risky and time-consuming process subject to a number of factors, many of which are outside of our control. We are subject to regulatory authority permissions and approvals, most importantly the FDA. Our drug candidate(s)/indications are at early and mid-stages of development. Consequently, we can provide no assurance of the successful and timely development of new drugs, and the failure to do so could cause us to cease operations.
We may elect to deregister our common stock under the Exchange Act and suspend our reporting obligations. Such deregistration and suspension would result in less disclosure about us and may negatively affect the liquidity and trading prices of our common stock.
http://www.ipharminc.com/
About Innovation Pharmaceuticals Inc.:
Established in 2007, and headquartered in Wakefield, Massachusetts, Innovation Pharmaceuticals Inc. (formerly Cellceutix Corporation) is a publicly traded biopharmaceutical company dedicated to discovering and advancing innovative medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications.
Through ongoing research and drug development efforts, Innovation is focused on improving the clinical care of patients, as well as growing shareholder value. Our team consists of a diverse and accomplished group of professionals working together toward achieving this common goal.
IPIX CEO - "The Company historically devoted most of its efforts and resources on business development, regulatory matters, and clinical trials. Presently, the Company does not have sufficient financial resources to advance our drug candidates meaningfully." "In general, we expect to concentrate on product development and engage in a limited way in product discovery, avoiding the significant investment of time and financial resources that is generally required for a promising compound to be identified and brought into clinical trials." Source - https://www.sec.gov/ix?doc=/Archives/edgar/data/1355250/000147793223003414/ipix_10q.htm
More information is available at http://www.ipharminc.com.
Management: http://www.ipharminc.com/senior-management/
Scientific Advisors: http://www.ipharminc.com/scientific-advisors/
Clinical Trials: https://clinicaltrials.gov/ct2/results?cond=&term=%22Innovation+Pharmaceuticals%2C+Inc.%22++&cntry=&state=&city=&dist=&Search=Search&flds=abcefgps
Trials under previous name: https://clinicaltrials.gov/ct2/results?cond=&term=cellceutix&cntry=&state=&city=&dist=&Search=Search&flds=abcefgps
Product Pipeline: http://www.ipharminc.com/therapeutic-areas/
Recent News and Press Releases:
https://finance.yahoo.com/quote/IPIX?p=IPIX
http://www.ipharminc.com/press-release/
SEC Filings (CIK:0001355250): https://www.sec.gov/cgi-bin/browse-edgar?company=Innovation+Pharmaceutical&owner=exclude&action=getcompany
Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com
Share Structure: See SEC filing link above for current share structure
Investor Relations:
http://www.ipharminc.com/new-faq/
http://www.ipharminc.com/contact-us-1
Chart: https://stockcharts.com/h-sc/ui?s=IPIX
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock. Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |